Nduka M. Amankulor, MD
Neurosurgery
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurosurgery
Penn Medicine Provider

About me

  • Division Head, Neurosurgical Oncology
  • Director, Penn Brain Tumor Center
  • Presidential Associate Professor in Neurosurgery

Education and training

  • Medical School: Yale University
  • Residency: Yale-New Haven Hospital

What my patients think about me

Average Rating

150 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

September 2025
he is the best of the best
August 2025
please refer to prior statement.
August 2025
took time to explain things thoroughly
August 2025
i have and will recommend him to any and all needing neuro surgery

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Amankulor is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Kathryn Levy Feldman Geddy's Gift , The Pennsylvania Gazette: 2025


Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP, Flanders AE, Liem S, Lombardo J, Shi W, Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MP, O'Rourke DM, Mohan S, Davatzikos C; ReSPOND consortium. Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study , Neuro Oncol, 27: 2025,1102-1115


Till JE, Seewald NJ, Yazdani Z, Wang Z, Ballinger D, Samberg H, Dandu S, Macia C, Yin M, Abdalla A, Prior T, Shah SS, Patel T, McCoy E, Mansour M, Wills CA, Bochenek V, Serrano J, Snuderl M, Phillips RE, O'Rourke DM, Amankulor NM, Nabavizadeh A, Desai AS, Gollomp K, Binder ZA, Zhou W, Bagley SJ, Carpenter EL. Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma , Clin Cancer Res, 31: 2025,1292-1304


Pai EL, Matsumoto Y, Dou D, Nelluri S, Devi P, Priori S, Amankulor N, Alonso-Basanta M, Singh O, Abdullaev Z, Aldape K, Desai A, Mohan S, Nasrallah MP. Letter to the Editor: Molecularly defined oligodendroglioma evolving to osseous metastases , J Neuropathol Exp Neurol: 2025


Wen PY, Manzanera A, Duault C, Gonzalez-Kozlova E, Lopez L, Grossman SA, Ye X, Fisher J, Lee I, Walbert T, Snyder J, Brem S, Desai A, Bagley SJ, Kakani C, Strowd R, Tatter S, Laxton A, Lesser G, Amankulor N, Lieberman F, Drappatz J, Mantica M, Triggs D, Haymaker C, Wistuba II, Al-Atrash G, Mendoza Perez J, Futreal A, Little LD, Islam MDH, Duose D, Jiang P, Reuben A, Lawler SE, Pichavant M, Gentles A, Bendall S, Kong A, Camacho C, Del Valle D, Kim-Schulze S, Gnjatic S, Sharon E, Nowicki MO, Peruzzi P, Lane D, Aguilar-Cordova E, Aguilar LK, Nichols G, Dwyer J, Tak PP, Maecker H, Barone F, Chiocca EA. A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma , Neuro Oncol: 2025


Jonathan H. Sussman, Anthony R. Cillo, Sajeev, Carly Cardello, Jonathan Patterson, Ebrar Akca, Angelo Angione, David Moon, Katharine Krueger, Ali Ghamari, Emily Xu, Jessica Xu, Antonio C. Tarbay, Alex Li, Bhargavi R. Budihal, Xiaoran Zhang, Omar Elghawy, Wojciech K. Panek, Prajwal Rajappa, Kai Tan, Dario A.A. Vignali3, Tullia C. Bruno, Nduka M. Amankulor Single-cell profiling of peripheral and local immune compartments reveal unique genotype- independent prognostic immune signatures across IDH-stratified glioma , Neuro-Oncology: 2025


Rachel Blue Paul A. Soden John YK Lee Nduka Amankulor Brain Metastases and Neoplastic Meningitis , Abeloff's Clinical Oncology, 7th Edition: 2025


Mallela AN, Iheagwara UK, Fogg D, Anthony A, Gersey ZC, Zhang X, Abou-Al-Shaar H, Anand SK, Xu E, Zinn PO, Burton S, Quinn A, Ozhasoglu C, Clump DA, Siddiqui Z, Amankulor NM. Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency , J Neurosurg: 2024


Canella A, Nazzaro M, Artomov M, Rao Venkata LP, Thomas D, Lyberger J, Ukhatov A, Xing YL, Miller K, Behbehani G, Amankulor NM, Petritsch CK, Rajappa P. BRAF V600E in a preclinical model of pleomorphic Xanthoastrocytoma: Analysis of the tumor microenvironment and immune cell infiltration dynamics in vivo , Mol Ther Oncol, 32: 2024,200808


Rao A, Zhang X, Cillo AR, Sussman JH, Sandlesh P, Tarbay AC, Mallela AN, Cardello C, Krueger K, Xu J, Li A, Xu J, Patterson J, Akca E, Angione A, Jaman E, Kim WJ, Allen J, Venketeswaran A, Zinn PO, Parise R, Beumer J, Duensing A, Holland EC, Ferris R, Bagley SJ, Bruno TC, Vignali DAA, Agnihotri S, Amankulor NM. All-trans retinoic acid induces durable tumor immunity in IDH-mutant gliomas by rescuing transcriptional repression of the CRBP1-retinoic acid axis , bioRxiv: 2024